Primary Hypercortisolism.
Bravi CA.
Urol Clin North Am. 2025 May;52(2):193-204. doi: 10.1016/j.ucl.2025.01.002. Epub 2025 Feb 26.
Medical therapy in severe hypercortisolism.
Marques JVO, Boguszewski CL.
Best Pract Res Clin Endocrinol Metab. 2021 Mar;35(2):101487. doi: 10.1016/j.beem.2021.101487. Epub 2021 Jan 20.
Cushing's syndrome: Treatment and new therapeutic approaches.
Ferriere A, Tabarin A.
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101381. doi: 10.1016/j.beem.2020.101381. Epub 2020 Jan 30.
Recent Advances on Subclinical Hypercortisolism.
Zavatta G, Di Dalmazi G.
Endocrinol Metab Clin North Am. 2018 Jun;47(2):375-383. doi: 10.1016/j.ecl.2018.01.003. Epub 2018 Apr 9.
Evaluation and Treatment of Patients With Hypercortisolism: A Review.
Miller BS, Auchus RJ.
JAMA Surg. 2020 Dec 1;155(12):1152-1159. doi: 10.1001/jamasurg.2020.3280.
Update on Hypercortisolism Therapy.
Arnaldi G, Trementino L.
Front Horm Res. 2016;46:87-105. doi: 10.1159/000443869. Epub 2016 May 17.
Treating canine Cushing's syndrome: Current options and future prospects.
Sanders K, Kooistra HS, Galac S.
Vet J. 2018 Nov;241:42-51. doi: 10.1016/j.tvjl.2018.09.014. Epub 2018 Sep 27.
Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.
Golinelli S, de Marco V, Leal RO, Barbarossa A, Aniballi C, Maietti E, Tardo AM, Galac S, Fracassi F.
J Vet Intern Med. 2021 Nov;35(6):2616-2627. doi: 10.1111/jvim.16269. Epub 2021 Oct 21.
The landscape of bilateral adrenal incidentalomas associated with subclinical hypercortisolism.
Di Dalmazi G.
Endocrine. 2016 Sep;53(3):621-3. doi: 10.1007/s12020-016-1004-8. Epub 2016 Jul 1.
Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse.
Besemer F, Pereira AM, Smit JW.
Neth J Med. 2011 Jul-Aug;69(7):318-23.
